Cardinal Health Total Common and Preferred Stock Dividends Paid 2010-2025 | CAH

Cardinal Health annual/quarterly total common and preferred stock dividends paid history and growth rate from 2010 to 2025. Total common and preferred stock dividends paid can be defined as the cash outflow for all company dividends paid out to preferred and common shareholders.
  • Cardinal Health total common and preferred stock dividends paid for the quarter ending March 31, 2025 were $-0.374B, a 0.8% decline year-over-year.
  • Cardinal Health total common and preferred stock dividends paid for the twelve months ending March 31, 2025 were $-1.251B, a 2.87% decline year-over-year.
  • Cardinal Health annual total common and preferred stock dividends paid for 2024 were $-0.499B, a 4.95% decline from 2023.
  • Cardinal Health annual total common and preferred stock dividends paid for 2023 were $-0.525B, a 6.08% decline from 2022.
  • Cardinal Health annual total common and preferred stock dividends paid for 2022 were $-0.559B, a 2.44% decline from 2021.
Cardinal Health Annual Total Common and Preferred Stock Dividends Paid
(Millions of US $)
2024 $-499
2023 $-525
2022 $-559
2021 $-573
2020 $-569
2019 $-577
2018 $-581
2017 $-577
2016 $-512
2015 $-460
2014 $-415
2013 $-353
2012 $-300
2011 $-274
2010 $-253
2009 $-200
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $36.816B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Straumann Holding AG (SAUHY) Switzerland $21.909B 0.00
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 21.99
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40